Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
filingDate |
2019-10-16^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f1e697155fc752ab353e3ceb4c96a0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfee82999d07236647b2bfbf5163bfa8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_523f4a07260a50d472dc1c0670d75cf9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_415ff0dfe7def81aa80f89bba01ffb9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd63d0fd7fe02cc1c26ff9d9686f036b |
publicationDate |
2020-04-23^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020079040-A1 |
titleOfInvention |
4-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament |
abstract |
The present invention relates to novel 4-Pyrimidin-5-ylmethyl-morpho line derivatives of general formula (A) processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with NR2B negative allosteric modulating properties. |
priorityDate |
2018-10-17^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |